达拉图穆马
医学
硼替佐米
间质性肺病
甲基强的松龙
养生
泼尼松龙
多发性骨髓瘤
肺
内科学
外科
作者
Meng Chen,Lei Zhao,Fang Yao,Xiang Dong Yang
摘要
WHAT IS KNOWN AND OBJECTIVE: Daratumumab, an anti-CD38 monoclonalantibody, is a safe and effective antibody used in the treatment of multiple myeloma (MM), which is rarely reported to cause severe pulmonary complications. CASE SUMMARY: A 58-year-old man diagnosed with MM and preexisting interstitial lung disease developed a high fever and severe dyspnea after administering Daratumumab and bortezomib-containing regimen. Chest CT showed bilaterally and diffused ground-glass opacities and consolidations. A quick improvement was achieved in both clinical symptoms and chest imaging findings through the administration of large doses of methylprednisolone, followed by oral prednisolone. WHAT IS NEW AND CONCLUSION: This is the first case reporting Daratumumab and bortezomib-containing regimen-induced lung injury characterized by preexisting interstitial lung disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI